Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.
about
Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesisRisk factors for neoplastic progression in Barrett's esophagusCyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysisRisk factors for the development of oesophageal adenocarcinoma in Barrett's oesophagus: a UK primary care retrospective nested case-control study.Decreased risk of squamous cell carcinoma of the head and neck in users of nonsteroidal anti-inflammatory drugsEffect of medical and surgical treatment of Barrett's metaplasiaRisk factors and chemoprevention in Barrett's esophagus--an update.Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition.Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.Carcinogenesis of Barrett's esophagus: a review of the clinical literature.COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.Aspirin Use is Associated With Lower Risk of Barrett’s Esophagus in Women.The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett's oesophagus.
P2860
Q26766641-BD2A0F58-1A5D-40DF-90E6-3E07C6AA2C8AQ27002062-06671190-AB57-4EDF-9B93-A66761412B7EQ33555216-3E43C78D-FF65-43F5-B99F-402BAD5B0C80Q33695661-62A10EB5-F616-4979-BAAA-67A6743A0AF8Q33984604-D3F122F0-76B4-48B3-975D-7E4CD1C0C770Q34063700-F8C73E13-15A8-45D0-8116-FCA7F0C8F183Q34201351-A70C91CA-31B1-4277-9E04-0B9D391DEA23Q34898182-EB0566F3-8D09-47F0-B684-9707F7CBC228Q35954977-83AD30E3-5D08-4D0A-B205-49CA2F941B68Q37621036-2C3CA239-2B4D-450E-A0FF-3E5924BDED92Q38548565-F27FBABE-AF84-4060-8F01-545BE680FAE3Q39320644-EA11B101-DD5F-49E7-8E1E-534504021716Q49227522-153E3890-AD2C-4FEB-B227-603BBF85B9A0Q50510790-E7014096-523A-41C7-83F1-24082F3B7A5B
P2860
Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Aspirin is not chemoprotective ...... ophagus in multicentre cohort.
@en
Aspirin is not chemoprotective ...... ophagus in multicentre cohort.
@nl
type
label
Aspirin is not chemoprotective ...... ophagus in multicentre cohort.
@en
Aspirin is not chemoprotective ...... ophagus in multicentre cohort.
@nl
prefLabel
Aspirin is not chemoprotective ...... ophagus in multicentre cohort.
@en
Aspirin is not chemoprotective ...... ophagus in multicentre cohort.
@nl
P2093
P1476
Aspirin is not chemoprotective ...... sophagus in multicentre cohort
@en
P2093
Anthony Watson
Christine P Caygill
James R Ramus
Marc C Winslet
P304
P356
10.1097/CEJ.0B013E32832E0955
P407
P577
2009-09-01T00:00:00Z